Causal Relationship between Conformational Change and Inhibition of Domain Functions of Glycoxidative Fibronectin

References

• Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biological and clinical implications for diabetes and aging. Lab. Invest 1994; 70: 138–151
   PubMed Web of Science ®Google Scholar
• Wells‐Knecht M. C., Lyons T. J., McCance D. R., Thorpe S. R., Baynes J. W. Age‐dependent increase in ortho‐tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against oxidative stress in diabetes. J. Clin. Invest 1997; 100: 839–846
   PubMed Web of Science ®Google Scholar
• Meng J., Sakata N., Takebayashi S., Asano T., Futata T., Nagai R., Ikeda K., Horiuchi S., Myint T., Taniguchi N. Glycoxidation in aortic collagen from STZ‐induced diabetic rats and its relevance to vascular damage. Atherosclerosis 1998; 136: 355–365
   PubMed Web of Science ®Google Scholar
• Hynes R. O., Yamada K. M. Fibronectin: multifunctional modular glycoproteins. J. Cell. Biol 1982; 95: 369–377
   PubMed Web of Science ®Google Scholar
• Cohen M. P., Ku L. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation. Diabetes 1984; 33: 970–974
   PubMed Web of Science ®Google Scholar
• Krantz S., Lober M., Thiele M., Teuscher E. Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation. Exp. Clin. Endocrinol 1988; 91: 155–160
   PubMedGoogle Scholar
• Tarsio J. F., Reger L. A., Furcht L. T. Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation: implications for diabetes mellitus. Biochemistry 1987; 26: 1014–1020
   PubMed Web of Science ®Google Scholar
• Raabe H. M., Molsen H., Mlinaric S. M., Acil Y., Sinnecker G. H. G., Notbohm H., Kruse K., Muller P. K. Biochemical alterations in collagen IV induced by in vitro glycation. Biochem. J 1996; 319: 699–704
   PubMed Web of Science ®Google Scholar
• Fu M. X., Wells‐Knecht K. J., Blackledge J. A., Lyons T. J., Thorpe S. R., Baynes J. W. Glycation, glycoxidation, and cross‐linking of collagen by glucose. Diabetes 1994; 43: 676–683
   PubMed Web of Science ®Google Scholar
• Coussons P. J., Jacoby J., McKay A., Kelly S. M., Price N. C., Hunt J. V. Glucose modification of human serum albumin: a structural study. Free Rad. Biol. Med 1997; 22: 1217–1227
   PubMed Web of Science ®Google Scholar
• Sakai K., Fujii T., Hayashi T. Conformational change precedes the formation of multimeric fibronectin. J. Biochem 1996; 119: 58–62
   PubMed Web of Science ®Google Scholar
• Gilchrest B. A., Nemore R. E., Maciag T. Growth of human keratinocytes on fibronectin‐coated plates. Cell. Biol. Int. Rep 1980; 4: 1009–1016
   PubMedGoogle Scholar
• Ikeda K., Higashi T., Sano Ft., Jinnouchi Y., Yoshida M., Araki T., Ueda S., Horiuchi S. N‐(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075–8083
   PubMed Web of Science ®Google Scholar
• Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 1977; 20: 1–5
   PubMed Web of Science ®Google Scholar
• Lewinsohn D. M., Nickoloff B. J., Butcher E. C. A fluorometric approach to the quantitation of cell number with application to a cell adhesion assay. J. Immunol. Methods 1988; 110: 93–100
   PubMed Web of Science ®Google Scholar
• Sakata N., Fujimilsu K., Jimi S., Takebayashi S. PDGF‐growth factor from SV40‐transformed smooth muscle cells promotes growth in an autocrine or paracrine manner. Exp. Mol. Pathol 1994; 60: 39–51
   PubMed Web of Science ®Google Scholar
• Degenhardt T. P., Grass L., Reddy S., Thorpe S. R., Diamandis E. P., Bynes J. W. The serum concentration of the advanced glycation end‐product N‐(carboxymethyl)‐lysine is increased in uremia. Kidney Int 1997; 52: 1064–1067
   PubMed Web of Science ®Google Scholar
• Sell D. R., Monnier V. M. End‐stage renal disease and diabetes catalyze the formation of a pentose‐derived crosslink from aging human collagen. J. Clin. Invest 1990; 85: 380–384
   PubMed Web of Science ®Google Scholar
• Sakata N., Imanaga Y., Meng J., Tachikawa Y., Takebayashi S., Nagai R., Horiuchi S. Increased advanced glycation end products in atherosclerotic lesions of patients with end‐stage renal disease. Atherosclerosis 1999; 142: 67–77
   PubMed Web of Science ®Google Scholar
• Meng J., Sakata N., Imanaga Y., Tachikawa Y., Chihara J., Takebayashi S. Evidence for glycoxidation and lipoperoxidation in patients with chronic renal failure. Clin. Nephrol 1999; 51: 280–289
   PubMed Web of Science ®Google Scholar
• Ucsugi N., Sakata N., Nagai R., Johno T., Horiuchi S., Takebayashi S. Glycoxidative modification of AA amyloid deposits in renal tissue. Nephrol. Dial. Transplant, (in print)
   Web of Science ®Google Scholar
• Sakata N., Imanaga Y., Meng J., Tachikawa Y., Takebayashi S., Nagai R., Horiuchi S., Itabe H., Takano T. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis 1998; 141: 61–75
   PubMed Web of Science ®Google Scholar
• Ahmed M. U., Thorpe S. R., Baynes J. W. Identification of N‐carboxymethyl‐lysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem 1986; 261: 4889–4894
   PubMed Web of Science ®Google Scholar
• Mullarkey C. J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Comm 1990; 173: 932–939
   PubMed Web of Science ®Google Scholar
• Chase K. V., Carubelli R., Nordquist R. E. The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates. Arch. Biochem. Biophys 1991; 288: 473–480
   PubMed Web of Science ®Google Scholar
• Tanaka I., Kawamura N., Myint T., Miyazawa N., Suzuki K., Maruyama N., Mino M., Taniguchi N. Glycated Cu,Zn‐superoxide dismutase in rat lenses: evidence for the presence of fragmentation in vivo. Biochem. Biophys. Res. Commun 1996; 219: 243–248
   PubMed Web of Science ®Google Scholar
• Islam K. N., Takahashi M., Higashiyama S., Myint T., Urozumi N. Fragmentation of ceruloplasmin following non‐enzymatic glycation reaction. J. Biochem 1995; 118: 1054–1060
   PubMed Web of Science ®Google Scholar
• Hunt J. V., Wolff S. P. Oxidative glycation and free radical production, a causal mechanism of diabetic complications. Free Radic. Res. Commun 1991; 12–13(Ptl)115–123
   PubMedGoogle Scholar
• Charonis A. S., Reger L. A., Dege J. E., Kouzi‐Koliakos K., Furcht L. T., Wohlhueter R. M., Tsilibary E. C. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 1990; 39: 807–814
   PubMed Web of Science ®Google Scholar
• Tarsio J. F., Reger L. A., Furcht L. T. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association. Diabetes 1988; 37: 532–539
   PubMed Web of Science ®Google Scholar
• Haitoglou C. S., Tsilibary E. C., Brownlee M., Charonis A. S. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J. Biol. Chem 1992; 267: 12404–12407
   PubMed Web of Science ®Google Scholar
• Tarsio J. F., Wigness B., Rhode T. D., Rupp W. M., Buchwald H., Furcht L. T. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus. Diabetes 1985; 34: 477–484
   PubMed Web of Science ®Google Scholar
• Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491–496
   PubMed Web of Science ®Google Scholar
• Humphries M. J., Akiyama S. K., Komonya A., Olden K., Yamada K. M. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type‐specific adhesion. J. Cell. Biol 1986; 103: 2637–2647
   PubMed Web of Science ®Google Scholar
• Raabe H. M., Höpner J. H., Notbohm H., Sinnecker G. H. G., Kruse K., Müller P. K. Biochemical and biophysical alterations of the 7S and NCl domain of collagen IV from diabetic kidneys. Diabetologia 1998; 41: 1073–1079
   PubMed Web of Science ®Google Scholar
• Odermatt E., Engel J. Shape, conformation and stability of fibronectin fragments determined by electron microscopy, circular dichroism and ultracentrifugation. J. Mol. Biol 1982; 159: 109–123
   PubMed Web of Science ®Google Scholar
• Becker J. W., Reeke G. N., Jr. Three‐dimensional structure of β2‐microglobulin. Proc. Natl. Acad. Sci. USA 1985; 82: 4225–4229
   PubMed Web of Science ®Google Scholar
• Homma N., Gejyo F., Isemura M., Arakawa M. Collagen‐binding affinity of beta‐2‐microglobulin, a preprotein of hemodialysis‐associated amyloidosis. Nephron 1989; 53: 37–40
   PubMed Web of Science ®Google Scholar
• Baron M., Norman D., Willis A., Campbell L. A. Structure of the fibronectin type I module. Nature 1990; 345: 642–646
   PubMed Web of Science ®Google Scholar
• Main A. L., Harvey T. S., Baron M., Boyd J., Campbell L. D. The three‐dimensional structure of the tenth type III module of fibronectin: an insight into RGD‐mediated interactions. Cell 1992; 71: 671–678
   PubMed Web of Science ®Google Scholar
• Hammes H. P., Weiss A., Hess S., Araki N., Horiuchi S., Brownlee M., Preissner K. T. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab. Invest 1996; 75: 325–338
   PubMed Web of Science ®Google Scholar
• Chace K. V., Carubelli R., Nordquist R. S. The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates. Arch. Biochim. Biophys 1991; 288: 473–480
   PubMed Web of Science ®Google Scholar
• Sakai K., Fujii T., Hayashi T. Cell‐free formation of disulfide‐bonded multimer from isolated plasma fibronectin in the presence of a low concentration of SH reagent under a physiological condition. J. Biochem 1994; 115: 415–421
   PubMed Web of Science ®Google Scholar